Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?
- PMID: 21922053
- PMCID: PMC3173647
- DOI: 10.4161/trns.2.3.16172
Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?
Abstract
This review first discusses ways in which we can evaluate transcription inhibition, describe changes in nuclear structure due to transcription inhibition, and report on genes that are paradoxically stimulated by transcription inhibition. Next, it summarizes the characteristics and mechanisms of commonly used inhibitors: α-amanitin is highly selective for RNAP II and RNAP III but its action is slow, actinomycin D is fast but its selectivity is poor, CDK9 inhibitors such as DRB and flavopiridol are fast and reversible but many genes escape transcription inhibition. New compounds, such as triptolide, are fast and selective and able to completely arrest transcription by triggering rapid degradation of RNAP II.
References
-
- Sugaya K, Sasanuma S, Cook PR, Mita K. A mutation in the largest (catalytic) subunit of RNA polymerase II and its relation to the arrest of the cell cycle in G(1) phase. Gene. 2001;274:77–81. - PubMed
-
- Jackman J, Alamo IJ, Fornace AJJ. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res. 1994;54:5656–5662. - PubMed
-
- Lü X, Burgan WE, Cerra MA, Chuang EY, Tsai MH, Tofilon PJ, et al. Transcriptional signature of flavopiridol-induced tumor cell death. Mol Cancer Ther. 2004;3:861–872. - PubMed
-
- Chen Q, Cao M, Xiang WL, Sun Q, Zhang J, Hou RT, et al. Study on genes with altered expression in alpha-amanitin poisoned mice and evaluation on antagonistic effects of traditional Chinese medicines against toxicity of alpha-amanitin. Acta Biol Hung. 2009;60:281–291. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous